RUBY
Rubius Therapeutics Inc
Price:  
0.08 
USD
Volume:  
18,983,900.00
United States | Biotechnology
Valuation
Overview
Financials
Forecast
Compare
Historical Price
SolvencyDividends
Transactions
People

RUBY WACC - Weighted Average Cost of Capital

The WACC of Rubius Therapeutics Inc (RUBY) is 8.7%.

The Cost of Equity of Rubius Therapeutics Inc (RUBY) is 13.65%.
The Cost of Debt of Rubius Therapeutics Inc (RUBY) is 5.00%.

Range Selected
Cost of equity 11.10% - 16.20% 13.65%
Tax rate 26.20% - 27.00% 26.60%
Cost of debt 5.00% - 5.00% 5.00%
WACC 7.4% - 9.9% 8.7%
WACC

RUBY WACC calculation

Category Low High
Long-term bond rate 3.9% 4.4%
Equity market risk premium 4.6% 5.6%
Adjusted beta 1.58 2.03
Additional risk adjustments 0.0% 0.5%
Cost of equity 11.10% 16.20%
Tax rate 26.20% 27.00%
Debt/Equity ratio 1 1
Cost of debt 5.00% 5.00%
After-tax WACC 7.4% 9.9%
Selected WACC 8.7%